Improved Tumor Targeting of Anti-HER2 Nanobody Through N-Succinimidyl 4-Guanidinomethyl-3-Iodobenzoate Radiolabeling

Nanobodies are approximately 15-kDa proteins based on the smallest functional fragments of naturally occurring heavy chain–only antibodies and represent an attractive platform for the development of molecularly targeted agents for cancer diagnosis and therapy. Because the human epidermal growth fact...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Pruszynski, Marek, Koumarianou, Eftychia, Vaidyanathan, Ganesan, Revets, Hilde, Devoogdt, Nick, Lahoutte, Tony, Lyerly, H. Kim, Zalutsky, Michael R.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2014
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4157601/
https://ncbi.nlm.nih.gov/pubmed/24578241
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.113.127100
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia